Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $33.58 USD
Change Today -0.63 / -1.84%
Volume 642.0K
INSY On Other Exchanges
As of 8:10 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Daniel Douglas Von Hoff M.D., F.A.C.P.

AgeTotal Calculated CompensationThis person is connected to 567 board members in 56 different organizations across 84 different industries.

See Board Relationships


Dr. Daniel Douglas Von Hoff, also known as Dan, M.D., F.A.C.P., serves as a Senior Advisor of Clinical Development at Tolero Pharmaceuticals, Inc. Dr. Von Hoff serves as special advisor of Aptose Biosciences Inc. Dr. Von Hoff served as Senior Vice President of Medical Affairs at Aptose Biosciences Inc., since October 28, 2013. He served as its Senior Vice President of Clinical Development. He co-founded Cylene Pharmaceuticals, Inc. in 1998 and serves as its Senior Vice ...

Read Full Background

Corporate Headquarters*

1333 South Spectrum Boulevard
Chandler, Arizona 85286

United States

Phone: 480-500-3127
Fax: 602-910-2627

Board Members Memberships*

Co-Founder, Senior Vice President of Medical Affairs, Director and Member of Scientific Advisory Board
Co-Founder, Chief Medical Officer and Director
Chief Scientific Officer and Director


Carroll College (Montana)
Columbia University College of Physicians & Surgeons in New York

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INSY:US $33.58 USD -0.63


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INSYS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at